Fairmount logo

Fairmount

Crunchbase

Deals on record

2

Common Fundraising Type

Series C

Candid Therapeutics logo
Candid Therapeutics

Biotechnology • Autoimmune therapies

Venrock Healthcare Capital Partners logo
Vida Ventures logo
TCGX logo
Third Rock Ventures logo

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Equity
$370M
09/09/2024
Article
Bicara Therapeutics logo
Bicara Therapeutics

Biotechnology • Clinical-stage

TPG logo
Deerfield Management logo
Braidwell logo
Aisling Capital logo

Bicara Therapeutics is a clinical-stage biotech company focused on developing BCA101, a novel bifunctional inhibitor targeting EGFR and TGF-β pathways for the treatment of various cancers.

Series C
$165M
12/12/2023
Article